Search
for
Sort by
Research 421–450 of 638
- Cholesterol homeostasis in hair follicle keratinocytes is disrupted by impaired ABCA5 activity
- Current understanding and treatment of sex hormone-related hair diseases
- Effect of testosterone and its antagonists on knee range of motion through RXFP1 and RXFP2 regulation in rat model (911.12)
- Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats
- SERUM-CONCENTRATIONS OF Dehydroepyandrosterone-sulfate IN MEN WITH ANDROGENETIC ALOPECIA
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Structure and Expression of a New Complementary DNA Encoding the almost Exclusive 3β-Hydroxysteroid Dehydrogenase/Δ<sup>5</sup>-Δ<sup>4</sup>-lsomerase in Human Adrenals and Gonads
- Polycystic ovary syndrome
- The Role of Sebaceous Gland Activity and Scalp Microfloral Metabolism in the Etiology of Seborrheic Dermatitis and Dandruff
- The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
- Very-long-chain Acyl-CoA Synthetases
- Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium
- Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Estrogen and androgen signaling in the pathogenesis of BPH
- The human skin as a hormone target and an endocrine gland
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Corticotropin releasing hormone and the skin
- Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- PCOS and Depression: Common Links and Potential Targets
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches
- Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Short-Chain Fatty Acids from <i>Cutibacterium acnes</i> Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes